Literature DB >> 6743025

Biological functions of monospecific antibodies to envelope glycoproteins of Newcastle disease virus.

Y Umino, T Kohama, M Kohase, A Sugiura, H D Klenk, R Rott.   

Abstract

Monospecific antisera to HN and F glycoproteins of Newcastle disease virus were prepared, and their effects on the biological activities of the virus were investigated. Anti-HN serum inhibited hemagglutinating and neuraminidase activity, as well as hemolysis. Anti-F serum had no effect on hemagglutination or neuraminidase but inhibited hemolysis and virus-induced cell fusion. Anti-HN serum was highly neutralizing, while neutralization by anti-F serum was very inefficient in conventional plaque reduction tests, although both sera were estimated to contain comparable amounts of antibody reacting with the virus as indicated by complement fixation and immuno-diffusion tests. The neutralizing activity of anti-F serum was greatly enhanced by the addition of anti-IgG serum or fresh guinea pig serum, whereas that of anti-HN serum was little enhanced. Anti-HN serum incorporated in the agar overlay suppressed the development of plaques to some degree, while anti-F serum had little effect. The combination of anti-HN and anti-F sera resulted in a marked decrease in the number and size of plaques, demonstrating the synergistic effect of the two species of antibody in the containment of the spread of viral infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6743025     DOI: 10.1007/BF01309296

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  19 in total

1.  Sensitization of influenza virus A2-Singapore by antineuraminidase.

Authors:  M Majer; F Lik
Journal:  J Gen Virol       Date:  1971-11       Impact factor: 3.891

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  The characterization of monoclonal antibodies to Newcastle disease virus.

Authors:  P H Russell; P C Griffiths; K K Goswami; D J Alexander; M J Cannon; W C Russell
Journal:  J Gen Virol       Date:  1983-09       Impact factor: 3.891

4.  The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus.

Authors:  C Orvell; M Grandien
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

Review 5.  The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses.

Authors:  P W Choppin; A Scheid
Journal:  Rev Infect Dis       Date:  1980 Jan-Feb

6.  Immunologic properties of purified Sendai virus glycoproteins.

Authors:  C Orvell; E Norrby
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

7.  Effect of specific antibodies on biological functions of the envelope components of Newcastle disease virus.

Authors:  J T Seto; H Becht; R Rott
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

8.  Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells.

Authors:  H D Klenk; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1970-05       Impact factor: 11.205

9.  A labile component of normal serum which combines with various viruses; neutralization of infectivity and inhibition of hemagglutination by the component.

Authors:  H S GINSBERG; F L HORSFALL
Journal:  J Exp Med       Date:  1949-11       Impact factor: 14.307

Review 10.  Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection.

Authors:  D C Merz; A Scheid; P W Choppin
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more
  4 in total

1.  Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens.

Authors:  J Taylor; C Edbauer; A Rey-Senelonge; J F Bouquet; E Norton; S Goebel; P Desmettre; E Paoletti
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

2.  Protective effect of antibodies to two viral envelope glycoproteins on lethal infection with Newcastle disease virus.

Authors:  Y Umino; T Kohama; M Kohase; A Sugiura; H D Klenk; R Rott
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Mapping of three antigenic sites on the haemagglutinin-neuraminidase protein of Newcastle disease virus.

Authors:  K Yusoff; M Nesbit; H McCartney; P T Emmerson; A C Samson
Journal:  Virus Res       Date:  1988-11       Impact factor: 3.303

4.  Characterization of haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus expressed by a recombinant baculovirus.

Authors:  M Niikura; Y Matsuura; M Hattori; M Onuma; T Mikami
Journal:  Virus Res       Date:  1991-06       Impact factor: 3.303

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.